OTUD4 promotes the progression of glioblastoma by deubiquitinating CDK1 and activating MAPK signaling pathway

Mingxin Ci,Gaichao Zhao,Chongyang Li,Ruochen Liu,Xiaosong Hu,Jun Pan,Yang Shen,Guanghui Zhang,Yongsen Li,Li Zhang,Ping Liang,Hongjuan Cui

DOI: https://doi.org/10.1038/s41419-024-06569-x

2024-03-02

Cell Death and Disease

Abstract:Glioblastoma, IDH-Wild type (GBM, CNS WHO Grade 4) is a highly heterogeneous and aggressive primary malignant brain tumor with high morbidity, high mortality, and poor patient prognosis. The global burden of GBM is increasing notably due to limited treatment options, drug delivery problems, and the lack of characteristic molecular targets. OTU deubiquitinase 4 (OTUD4) is a potential predictive factor for several cancers such as breast cancer, liver cancer, and lung cancer. However, its function in GBM remains unknown. In this study, we found that high expression of OTUD4 is positively associated with poor prognosis in GBM patients. Moreover, we provided in vitro and in vivo evidence that OTUD4 promotes the proliferation and invasion of GBM cells. Mechanism studies showed that, on the one hand, OTUD4 directly interacts with cyclin-dependent kinase 1 (CDK1) and stabilizes CDK1 by removing its K11, K29, and K33-linked polyubiquitination. On the other hand, OTUD4 binds to fibroblast growth factor receptor 1 (FGFR1) and reduces FGFR1's K6 and K27-linked polyubiquitination, thereby indirectly stabilizing CDK1, ultimately influencing the activation of the downstream MAPK signaling pathway. Collectively, our results revealed that OTUD4 promotes GBM progression via OTUD4-CDK1-MAPK axis, and may be a prospective therapeutic target for GBM treatment.

cell biology

What problem does this paper attempt to address?

The paper aims to explore the role and potential mechanisms of OTUD4 in glioblastoma (GBM). The main research questions include:

1. **Expression and Prognostic Significance of OTUD4 in Glioblastoma**:
- The study found that OTUD4 is highly expressed in glioblastoma, and this high expression is associated with poor prognosis in patients.

2. **Impact of OTUD4 on Glioblastoma Cell Proliferation and Invasion**:
- The paper demonstrates through in vitro and in vivo experiments that OTUD4 can promote the proliferation and invasion capabilities of glioblastoma cells.

3. **Mechanism of Action of OTUD4**:
- Mechanistic studies indicate that OTUD4 stabilizes CDK1 protein levels by deubiquitinating it and indirectly affects the activation of the downstream MAPK signaling pathway by deubiquitinating FGFR1.
- Specifically, OTUD4 directly interacts with CDK1, removing its polyubiquitin chains at K11, K29, and K33 sites; and by deubiquitinating FGFR1, it reduces its polyubiquitin chains at K6 and K27 sites, thereby indirectly stabilizing CDK1.

4. **Correlation in Clinical Samples**:
- Immunohistochemistry experiments show that in clinical samples, those with high OTUD4 expression often have higher CDK1 staining intensity, and the expression of OTUD4 is positively correlated with CDK1.

In summary, the paper reveals that OTUD4 promotes the development of glioblastoma through the OTUD4-CDK1-MAPK axis and may become a new target for the treatment of glioblastoma.